LucenceINSIGHT™– Multi-Cancer Early Detection (MCED) Test

*This test is not intended for diagnosis and should be used in consultation with a healthcare provider.

  • LucenceINSIGHT™ is a next-generation sequencing (NGS) multi-cancer early detection (MCED) test that screens for up to 50 cancers with a single blood draw. It utilizes amplicon-based mirror barcoding technology to detect circulating tumor and viral DNA while leveraging machine learning to predict tumor location.

  • Next-generation sequencing technology for superior accuracy
    ✔ Covers cancers that traditional screenings miss
    ✔ Earlier detection = better treatment outcomes and survival rates
    ✔ Physician-trusted and clinically validated

    • Those with an elevated cancer risk (family history, lifestyle, or environmental factors)

    • People looking for a non-invasive, comprehensive screening solution

    ⚠️ Not Recommended For:
    ❌ Pregnant women
    ❌ Patients in cancer remission for less than 3 years
    ❌ Individuals who have had allogeneic bone transplants or recent blood transfusions (<2 weeks)

  • Get in touch with our clinic for more information about LucenceINSIGHT™

    Landline: (65) 6911 0100

    Email: PMG@pointmedical.com.sg